cyclosporine has been researched along with Cardiac Diseases in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (10.53) | 18.2507 |
| 2000's | 22 (57.89) | 29.6817 |
| 2010's | 12 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Liu, J; Liu, X; Liu, Z | 1 |
| Boston-Griffiths, E; Chaubey, S; Desai, J; Hausenloy, Dj; John, L; Kolvekar, S; Kunst, G; Yellon, D | 1 |
| Bolli, R; Chamuleau, ME; Chamuleau, SA; Doevendans, PA; Hart, E; Jansen Of Lorkeers, SJ; Tang, XL | 1 |
| Muehlschlegel, JD | 1 |
| Angoulvant, D; Bastien, O; Chiari, P; Desebbe, O; Farhat, F; Jegaden, O; Lehot, JJ; Mewton, N; Obadia, JF; Ovize, M; Robin, J | 1 |
| Andersson, B; Andreassen, AK; Arora, S; Aukrust, P; Bøtker, HE; Dellgren, G; Eiskjaer, H; Erikstad, I; Gude, E; Gullestad, L; Gustafsson, F; Ioanes, D; Rådegran, G; Sigurdardottir, V; Solberg, OG; Solbu, D; Ueland, T | 1 |
| Crippa, A; D'Elia, E; Eleftheriou, G; Fiocchi, R; Freddi, C; Introna, M; Sebastiani, R; Strobelt, N; Vittori, C | 1 |
| Andersson, B; Andreassen, AK; Arora, S; Dellgren, G; Eiskjaer, H; Gude, E; Gullestad, L; Gustafsson, F; Jansson, K; Karason, K; Rådegran, G; Solbu, D | 1 |
| Arif, K; Atilla, II; Aydin, K; Burak, U; Ebru, U; Emin, M; Faruk, TH; Kemal, E; Reyhan, B; Semsettin, S; Yusuf, S | 1 |
| Agüero, J; Almenar Bonet, L; Martínez-Dolz, L; Moro, JA; Raso, R; Salvador, A; Sánchez-Lázaro, I | 1 |
| Demartini, G; Fraschini, F; Gasco, MR; Musicanti, C; Reiter, RJ; Rezzani, R; Rodella, LF | 1 |
| Chen, YS; Chi, NH; Chou, NK; Huang, SC; Ko, WJ; Shun, CT; Tsao, CI; Wang, CH; Wang, SS; Wu, IH; Yu, HY | 1 |
| Baba, HA; Brand, M; Di Marco, GS; Grabner, A; Jacobi, AM; Kentrup, D; Pavenstädt, H; Reuter, S; Tiemann, K; Ting, L | 1 |
| Beauvillain, JC; Hassoun, SM; Lancel, S; Marchetti, P; Marciniak, C; Marechal, X; Montaigne, D; Neviere, R | 1 |
| Akcan, B; Al, S; Alkanat, M; Ersöz, S; Kaynar, K; Orem, A; Ozkan, G; Ulusoy, S; Yuluğ, E | 1 |
| Davidson, A; Dick, G; Pinkerton, R; Pritchard-Jones, K | 1 |
| Eisen, H; Ross, H | 1 |
| Chang, SW; Freeman, JC; Mikolajczak, P; Mott, JL; Zassenhaus, HP; Zhang, D | 1 |
| Angermann, CE; Costard-Jäckle, A; Dengler, TJ; Haaff, B; Nägele, H; Pethig, K; Rahmel, A; Schwarz, ER; Siebert, U; Störk, S; Tenderich, G; Wagner, FM | 1 |
| Reichenspurner, H | 1 |
| Bianchi, R; Bonomini, F; Buffoli, B; Giugno, L; Rezzani, R | 1 |
| Besner, JG; Cantarovich, M; Cecere, R; Giannetti, N; Mardigyan, V | 1 |
| Furukawa, H; Kawano, J; Kobashigawa, JA; Laks, H; Marquez, A; Moriguchi, JD; Oeser, BT; Patel, J; Shaw, J; Subherwal, S; Takemoto, S; Wu, GW; Yeatman, L | 1 |
| Alam, S; Arnaout, MS; Dimasi, A; Harb, R | 1 |
| Akcay, A; Bayrak, R; Karanfil, A; Kaya, A; Ozkara, A; Sahin, S; Selcoki, Y; Uz, B; Uz, E | 1 |
| Kiberd, B; Panek, R | 1 |
| Baron, O; Bizouarn, P; Despins, P; Duveau, D; Gueffet, JP; Habash, O; Heymann, MF; Lamirault, G; Michaud, JL; Mugniot, A; Pattier, S; Périgaud, C; Petit, T; Roussel, JC; Treilhaud, M; Trochu, JN | 1 |
| Hunninghake, DB; Kashtan, CE; Matas, AJ; Myers, TA; Sharma, AK | 1 |
| Bellamy, WT; Ellsworth, L; Grogan, TM; Odeleye, A; Peng, YM; Weinstein, RS; Xu, MJ | 1 |
| Annalisa, A; Antonio, G; Massimo, F; Maurizio, PG; Panagiotis, T; Sara, P; Sartori, TM; Ugolino, L | 1 |
| Bieringer, M; Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Mervaala, E; Müller, DN; Park, JK; Schmidt, F | 1 |
| Ahonen, J; Karppanen, H; Krogerus, L; Lindgren, L; Mervaala, EM; Pere, AK | 1 |
| Andrews, D; Colby, C; Cox, B; Foley, A; McAfee, S; Multani, P; Poliquin, C; Preffer, F; Sachs, DH; Sackstein, R; Saidman, S; Spitzer, TR; Sykes, M; Toh, HC; Weyouth, DW | 1 |
| Knuuttila, ML; Pernu, HE | 1 |
| Knuuttila, ML; Nurmenniemi, PK; Pernu, HE | 1 |
| Cattini, PA; Jimenez, SK; Kardami, E; Meij, JT; Nickerson, PW; Sheikh, F | 1 |
| Araujo, G; Ferrer, J; Parisi, C; Romeo, L; Sgrosso, JL; Vázquez, MC | 1 |
| Baum, D; Bernstein, D; Gamberg, P; Miller, J; Oyer, PE; Shumway, NE; Starnes, VA | 1 |
3 review(s) available for cyclosporine and Cardiac Diseases
| Article | Year |
|---|---|
Cyclosporin in cell therapy for cardiac regeneration.
Topics: Animals; Cell Survival; Cyclosporine; Disease Models, Animal; Drug Administration Schedule; Graft Survival; Heart Diseases; Humans; Immunosuppressive Agents; Regeneration; Stem Cell Transplantation; Stem Cells; Swine; Time Factors; Treatment Outcome | 2014 |
Optimizing the immunosuppressive regimen in heart transplantation.
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Everolimus; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus | 2004 |
Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
Topics: Cyclosporine; Graft Rejection; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Lung Diseases; Lung Transplantation; Tacrolimus; Treatment Outcome | 2005 |
9 trial(s) available for cyclosporine and Cardiac Diseases
| Article | Year |
|---|---|
The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial.
Topics: Aged; Coronary Artery Bypass; Cyclosporine; Double-Blind Method; Female; Heart Diseases; Humans; Immunosuppressive Agents; Male; Prospective Studies | 2014 |
Cyclosporine protects the heart during aortic valve surgery.
Topics: Aged; Anesthesia; Aortic Valve; Cyclosporine; Echocardiography; Endpoint Determination; Female; Heart Diseases; Humans; Immunosuppressive Agents; Intraoperative Complications; Male; Middle Aged; Myocardial Reperfusion Injury; Perioperative Period; Postoperative Complications; Prospective Studies; Sample Size; Single-Blind Method; Treatment Outcome; Troponin I | 2014 |
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
Topics: Adult; Allografts; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Prognosis; Risk Factors; Sirolimus; Transplant Recipients; Vascular Diseases | 2015 |
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.
Topics: Adolescent; Adult; Aged; Allografts; Calcineurin Inhibitors; Cyclosporine; Everolimus; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Prognosis; Prospective Studies; Risk Factors; Transplant Recipients; Vascular Diseases; Withholding Treatment; Young Adult | 2016 |
Randomized prospective study of the evolution of renal function depending on the anticalcineurin used.
Topics: Aged; Calcineurin Inhibitors; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Mycophenolic Acid; Pregnenediones; Tacrolimus | 2008 |
Can cyclosporine blood level be reduced to half after heart transplantation?
Topics: Adolescent; Adult; Aged; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Everolimus; Female; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Patient Selection; Sirolimus; Tissue Donors; Young Adult | 2010 |
Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients--the IMPROVED multi-centre study.
Topics: Cyclosporine; Female; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Treatment Outcome | 2004 |
Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
Topics: Adult; Antihypertensive Agents; Coronary Stenosis; Cyclosporine; Emulsions; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Diseases; Heart Transplantation; Humans; Hypertension; Hypertriglyceridemia; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Survival Analysis; Tacrolimus; Time Factors; Treatment Outcome | 2006 |
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
Topics: Adult; Animals; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Genotype; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Heart Diseases; Hematologic Neoplasms; Histocompatibility; HLA Antigens; Humans; Leukocyte Transfusion; Male; Mice; Middle Aged; Models, Animal; Phenotype; Remission Induction; Reproducibility of Results; Salvage Therapy; Survival Analysis; T-Lymphocytes; Thymus Gland; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2000 |
26 other study(ies) available for cyclosporine and Cardiac Diseases
| Article | Year |
|---|---|
Cyclosporine A attenuates cardiac dysfunction induced by sepsis via inhibiting calcineurin and activating AMPK signaling.
Topics: Acetyl-CoA Carboxylase; Animals; Biomarkers; Blood Pressure; Calcineurin Inhibitors; Carnitine O-Palmitoyltransferase; Cyclosporine; Disease Models, Animal; Heart Diseases; Heart Function Tests; Male; MAP Kinase Signaling System; Myocardium; Rats; Sepsis; Ventricular Dysfunction | 2017 |
Closing the pore on reperfusion injury: myocardial protection with cyclosporine.
Topics: Aortic Valve; Cyclosporine; Female; Heart Diseases; Humans; Immunosuppressive Agents; Intraoperative Complications; Male; Myocardial Reperfusion Injury; Postoperative Complications | 2014 |
First Report of a Successful Pregnancy in an Everolimus-Treated Heart-Transplanted Patient: Neonatal Disappearance of Immunosuppressive Drugs.
Topics: Adult; Cyclosporine; Everolimus; Female; Graft Survival; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Infant, Newborn; Postoperative Complications; Pregnancy; Pregnancy Outcome; Tissue Distribution | 2016 |
Cardioprotective effects of Nigella sativa oil on cyclosporine A-induced cardiotoxicity in rats.
Topics: Animals; Antioxidants; Catalase; Cyclosporine; Glutathione Peroxidase; Heart Diseases; Immunosuppressive Agents; Male; Malondialdehyde; Myocardium; Phytotherapy; Plant Oils; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase | 2008 |
Melatonin delivery in solid lipid nanoparticles: prevention of cyclosporine A induced cardiac damage.
Topics: Analysis of Variance; Animals; Apoptosis; Cyclosporine; Drug Carriers; Heart Diseases; Immunosuppressive Agents; In Situ Nick-End Labeling; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Melatonin; Myocardium; Nanoparticles; Nitric Oxide Synthase Type II; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar | 2009 |
Cardioprotective effect of calcineurin inhibition in an animal model of renal disease.
Topics: Animals; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Heart Diseases; Hypertrophy, Left Ventricular; Immunosuppressive Agents; Kidney Diseases; Male; Nephrectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Tacrolimus; Ventricular Remodeling | 2011 |
Doxorubicin-induced cardiac dysfunction is attenuated by ciclosporin treatment in mice through improvements in mitochondrial bioenergetics.
Topics: Animals; Antibiotics, Antineoplastic; Cyclosporine; DNA Primers; DNA, Mitochondrial; Doxorubicin; Heart Diseases; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardium; Permeability; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Antiapoptotic and antioxidant effects of GSPE in preventing cyclosporine A-induced cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Cyclosporine; Disease Models, Animal; Female; Free Radical Scavengers; Grape Seed Extract; Heart; Heart Diseases; Immunosuppressive Agents; In Situ Nick-End Labeling; Myocardium; Oxidative Stress; Proanthocyanidins; Rats; Rats, Sprague-Dawley; Vitis | 2012 |
EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin)-chemotherapy selected for multidrug resistance modulation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Kidney Diseases; Male; Neoplasms; Vincristine | 2002 |
Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A.
Topics: Animals; Cell Death; Connexin 43; Cyclosporine; Dilatation, Pathologic; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Enzyme Inhibitors; Heart Diseases; Immunosuppressive Agents; Mice; Mice, Transgenic; Mitochondria; Mutation; Myocardium; Tacrolimus | 2004 |
The protective effect of caffeic acid phenethyl ester against cyclosporine A-induced cardiotoxicity in rats.
Topics: Animals; Caffeic Acids; Cyclosporine; Electron Transport Complex IV; Heart Diseases; Immunosuppressive Agents; Male; Matrix Metalloproteinase 2; Myocardium; Phenylethyl Alcohol; Protective Agents; Rats; Rats, Wistar; Reactive Oxygen Species; Tissue Inhibitor of Metalloproteinase-2 | 2005 |
Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
Topics: Adult; Aged; Area Under Curve; Calcineurin Inhibitors; Cardiomyopathies; Cyclosporine; Drug Interactions; Drug Monitoring; Enzyme Inhibitors; Heart Diseases; Heart Neoplasms; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Tacrolimus; Time Factors | 2005 |
Unusual thrombotic cardiac complications of Pemphigus vulgaris: a new link?
Topics: Adult; Anticoagulants; Cyclosporine; Diagnostic Imaging; Heart Diseases; Heparin; Humans; Male; Myocardial Infarction; Pemphigus; Pulmonary Embolism; Steroids; Thrombosis | 2007 |
The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Topics: Animals; Catalase; Chemoprevention; Cyclosporine; Disease Models, Animal; Expectorants; Fibrosis; Glutathione Peroxidase; Heart; Heart Diseases; Immunosuppressive Agents; Male; Malondialdehyde; Myocardium; Nitric Oxide; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase; Thioglycolates; Thiophenes | 2007 |
Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited.
Topics: Adult; Age Factors; Aged; Ambulatory Care Facilities; Cardiovascular Agents; Cyclosporine; Diabetes Complications; Disease-Free Survival; Female; Health Status Indicators; Heart Diseases; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Stroke; Tacrolimus; Time Factors | 2008 |
Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality.
Topics: Cyclosporine; Female; Graft Rejection; Graft Survival; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Morbidity; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2008 |
Hyperlipidemia in long-term survivors of pediatric renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Heart Diseases; Humans; Hypercholesterolemia; Hyperlipidemias; Kidney Transplantation; Male; Minnesota; Prednisone; Prevalence; Risk Factors; Triglycerides | 1994 |
Cardiotoxicity in the SCID mouse following administration of doxorubicin and cyclosporin A.
Topics: Animals; Antibiotics, Antineoplastic; Cell Transplantation; Chromatography, High Pressure Liquid; Cyclosporine; Doxorubicin; Drug Interactions; Heart Diseases; Humans; Kidney; Mice; Mice, Inbred BALB C; Mice, SCID; Multiple Myeloma; Myocardium; Neoplasm Transplantation; Rats; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1995 |
Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation.
Topics: Azathioprine; Biopsy; Coronary Artery Disease; Cyclosporine; Drug Therapy, Combination; Female; Fibrinolysis; Glucocorticoids; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardium; Postoperative Care; Prednisone; Thrombosis; Time Factors | 1999 |
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Diseases; Humans; Hypertension, Renal; Interleukin-6; Kidney; Male; Monocytes; Myocardium; Neutrophils; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Binding; Rats; Renin | 2000 |
Beneficial effects of dietary magnesium and potassium on cardiac and renal morphologic features in cyclosporin A-induced damage in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Cyclosporine; Heart Diseases; Immunosuppressive Agents; Kidney Diseases; Magnesium; Male; Potassium, Dietary; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sodium, Dietary | 2000 |
Macrophages and lymphocyte subpopulations in nifedipine- and cyclosporin A-associated human gingival overgrowth.
Topics: Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, CD20; Antigens, Differentiation, Myelomonocytic; B-Lymphocytes; Calcium Channel Blockers; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Count; Connective Tissue; Cyclosporine; Epithelium; Female; Gingiva; Gingival Overgrowth; Heart Diseases; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Count; Lymphocyte Subsets; Macrophages; Male; Nifedipine; Statistics as Topic; Statistics, Nonparametric | 2001 |
Mitotic activity of keratinocytes in nifedipine- and immunosuppressive medication-induced gingival overgrowth.
Topics: Adult; Aged; Azathioprine; Calcium Channel Blockers; Cell Count; Cyclosporine; Epithelial Cells; Epithelium; Female; Gingiva; Gingival Overgrowth; Glucocorticoids; Heart Diseases; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Keratinocytes; Ki-67 Antigen; Male; Middle Aged; Mitosis; Nifedipine; Organ Transplantation; Prednisolone; Statistics as Topic; Statistics, Nonparametric | 2001 |
Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent.
Topics: Animals; Antibodies, Monoclonal; CD3 Complex; Cyclosporine; Female; Fibroblast Growth Factor 2; Gene Expression; Heart Diseases; Immunosuppressive Agents; Isoproterenol; Male; Mice; Mice, Inbred Strains; Mice, Transgenic; Myocardium; Receptors, Antigen, T-Cell; Sympathomimetics; T-Lymphocytes | 2002 |
Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Time Factors | 2002 |
Heart, heart-lung, and lung transplantation in the first year of life.
Topics: Actuarial Analysis; Cause of Death; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Defects, Congenital; Heart Diseases; Heart Transplantation; Heart-Lung Transplantation; Humans; Infant; Infant, Newborn; Lung Transplantation; Male; Postoperative Complications | 1992 |